Safety of Ferric Citrate in Children with High Blood Phosphate Due to Kidney Disease
In this study we want to gather more information about the safety and tolerability of a drug called ferric citrate for treating children with chronic kidney disease who have hyperphosphatemia.
Why this Research Matters
Hyperphosphatemia is an electrolyte disorder in which there is a higher-than-normal level of phosphate in the blood. This is often caused by chronic kidney disease. If you/your child joins this study, you will come to 12 visits over about 9 months at Child
Who can Participate
You/your child may be a good fit for this study if you are between 6 and 17 years old and have been diagnosed with chronic kidney disease by a doctor. Please note, if you are interested in joining this study, our team will check to make sure the study is a
Study ID
Protocol Number: 23-0073
Meet the Team
Principal Investigator